Advancing Drug Discovery
Kantify has built a platform to accelerate the discovery of new drugs in silico. This next generation technology called ZeptoNet enables our pharma and biotech partners to improve target identification, hit discovery, hit optimization and ADMET optimization thanks to Artificial Intelligence. The technology has shown extremely promising results in several diseases including rare diseases.
Diagnosis and Clinical Decision Support
Kantify is developing AI solutions for diagnosis and clinical decision support. As a CRO, we help developing solutions in oncology, ophthalmology, hematology and other. Our expertise in AI for healthcare enables us to understand and tackle challenges in various therapeutical areas, using different datasets and sources.
Kantify is enabling life science organizations to accelerate the analysis of data, samples and other kind of clinical data thanks to Artificial Intelligence. Our expertise in several techniques within Artificial Intelligence enables us to tackle various kinds of data and technical challenges.